Dabur Pharma made a debut at Rs 30.05, witnessing a volatile trading session. The stock in intra-day trades touched a high of Rs 52.25 and a low of Rs 27.05, before closing at Rs 39.35 on the BSE. The counter witnessed volumes of more than 1.15 lakh shares on the BSE. |
Dabur Pharma was listed on the bourses after exercising restructuring, splitting the company's pharma and FMCG business. Shareholders received one share of Dabur Pharma for every 2 shares held in Dabur India. |
|
Dabur Pharma recorded a 16.4 per cent growth in net profit to Rs 18.1 crore in 2003-04 from Rs 15.5 crore in the previous fiscal. Sales rose 16.2 per cent to Rs 213.6 crore in FY04 from Rs 183.8 crore during the corresponding period a year ago. |
|
Both Dabur India and Dabur Pharma have a face value of rupee one. Dabur Pharma has a paid-up equity capital of Rs 14.36 crore. Dabur India, however, ended marginally lower at Rs 72.90, down 0.61 per cent from its previous close. |
|
|
|